Reduced Dosage of Bruton’s Tyrosine Kinase Uncouples B Cell Hyperresponsiveness from Autoimmunity in lyn−/− Mice1

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Immunology

• Publication date

  2003-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.171.4.1850PMID 12902486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transitional B Lymphocyte Subsets Operate as Distinct Checkpoints in Murine Splenic B Cell Development1

  2002cited by this paper
• Transitional Type 1 and 2 B Lymphocyte Subsets Are Differentially Responsive to Antigen Receptor Signaling*

  2002cited by this paper
• Unique Signaling Properties of B Cell Antigen Receptor in Mature and Immature B Cells: Implications for Tolerance and Activation1

  2001cited by this paper
• B cell receptor signaling and autoimmunity

  2001cited by this paper
• A conditional form of Bruton's tyrosine kinase is sufficient to activate multiple downstream signaling pathways via PLC Gamma 2 in B cells

  2001cited by this paper
• A CD19-Dependent Signaling Pathway Regulates Autoimmunity in Lyn-Deficient Mice1

  2001cited by this paper
• PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine

  2001cited by this paper
• CD19 Amplification of B Lymphocyte Ca2+ Responses

  2001cited by this paper
• Selection events operating at various stages in B cell development.

  2001cited by this paper
• B-Cell Kinase Lyn Deficiency in Patients With Systemic Lupus Erythematosus

  2001cited by this paper
• Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage.

  2001cited by this paper
• Novel Roles for Lyn in B Cell Migration and Lipopolysaccharide Responsiveness Revealed Using Anti-Double-Stranded DNA Ig Transgenic Mice1

  2001cited by this paper
• Cutting Edge Commentary: Origins of B-1 Cells1 2

  2001cited by this paper
• Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

  2000cited by this paper
• B Cell Antigen Receptor-Induced Activation of Akt Promotes B Cell Survival and Is Dependent on Syk Kinase1

  2000cited by this paper
• Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

  2000cited by this paper
• Akt-Dependent Cytokine Production in Mast Cells

  2000cited by this paper
• Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.

  2000cited by this paper
• Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies.

  1999influential reference
• Deficiency in CD22, a B Cell–specific Inhibitory Receptor, Is Sufficient to Predispose to Development of High Affinity Autoantibodies

  1999cited by this paper
• Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1

  1999cited by this paper
• Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.

  1999cited by this paper
• Syk and Bruton's Tyrosine Kinase Are Required for B Cell Antigen Receptor-mediated Activation of the Kinase Akt*

  1999cited by this paper
• Constitutive tyrosine phosphorylation of the inhibitory paired Ig-like receptor PIR-B.

  1999cited by this paper
• Epistatic modifiers of autoimmunity in a murine model of lupus nephritis.

  1999cited by this paper
• Regulation of B‐1 cell activation and its autoantibody production by Lyn kinase‐regulated signallings

  1999influential reference
• The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt/PKB in B lymphocytes.

  1999cited by this paper
• SHIP modulates immune receptor responses by regulating membrane association of Btk.

  1998cited by this paper
• Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.

  1998cited by this paper
• Inhibition of the B Cell by CD22: A Requirement for Lyn

  1998cited by this paper
• Phosphatidylinositol‐3,4,5‐trisphosphate (PtdIns‐3,4,5‐P3)/Tec kinase‐dependent calcium signaling pathway: a target for SHIP‐mediated inhibitory signals

  1998cited by this paper
• A Double-Edged Kinase Lyn: A Positive and Negative Regulator for Antigen Receptor–mediated Signals

  1998influential reference
• The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation.

  1998cited by this paper
• Independent and Opposing Roles For Btk and Lyn in B and Myeloid Signaling Pathways

  1998cited by this paper
• Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses.

  1998cited by this paper
• Different Protein Tyrosine Kinases Are Required for B Cell Antigen Receptor–mediated Activation of Extracellular Signal–Regulated kinase, c-Jun NH2-terminal Kinase 1, and p38 Mitogen-activated Protein Kinase

  1998cited by this paper
• Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.

  1998cited by this paper
• The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105

  1998cited by this paper
• Abrogation of autoimmune disease in Lyn-deficient mice by the mutation of the Btk gene.

  1998influential reference
• Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B‐cell receptor activation

  1998cited by this paper
• A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5.

  1997cited by this paper
• Btk dosage determines sensitivity to B cell antigen receptor cross-linking.

  1997cited by this paper
• Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation.

  1997cited by this paper
• DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance.

  1997cited by this paper
• Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice.

  1996cited by this paper
• IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses.

  1996influential reference
• Hyperresponsive B Cells in CD22-Deficient Mice

  1996cited by this paper
• CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.

  1996cited by this paper
• Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre‐B cell stage.

  1996cited by this paper
• Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice

  1996cited by this paper
• Defective B cell development and function in Btk-deficient mice.

  1995cited by this paper
• Defective IL-5-receptor-mediated signaling in B cells of X-linked immunodeficient mice.

  1995cited by this paper
• Administration of interleukin ‐5 or ‐10 activates peritoneal B‐1 cells and induces autoimmune hemolytic anemia in anti‐erythrocyte autoantibody‐transgenic mice

  1995cited by this paper
• Ofloxacin and fleroxacin enhance superoxide production in human polymorphonuclear leukocytes by increasing phosphorylation in the signal transduction pathway.

  1995cited by this paper
• Impaired expansion of mouse B cell progenitors lacking Btk.

  1995cited by this paper
• Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease.

  1995cited by this paper
• Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines.

  1995cited by this paper
• Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells.

  1995cited by this paper
• CD38 unresponsiveness of xid B cells implicates Bruton's tyrosine kinase (btk) as a regular of CD38 induced signal transduction.

  1995cited by this paper
• Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.

  1995cited by this paper
• Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

  1994cited by this paper
• Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells

  1994cited by this paper
• Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.

  1994cited by this paper
• Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice.

  1993cited by this paper
• Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.

  1993cited by this paper
• Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

  1993cited by this paper
• Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice

  1993influential reference
• The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

  1993cited by this paper
• Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.

  1993cited by this paper
• Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells

  1992influential reference
• Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice

  1991cited by this paper
• Ig H and L chain contributions to autoimmune specificities.

  1991cited by this paper
• Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production

  1991cited by this paper
• Elimination from peripheral lymphoid tissues of self-reactive B lymphocytes recognizing membrane-bound antigens

  1991influential reference
• Possible role of IL-6 in pathogenesis of immune complex-mediated glomerulonephritis in NZB/W F1 mice: induction of IgG class anti-DNA autoantibody production.

  1990cited by this paper
• Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

  1990cited by this paper
• Analysis of signaling via surface immunoglobulin receptors on b cells from cba/n mice

  1989cited by this paper
• Increased autoantibody production by NZB/NZW B cells in response to IL-5.

  1988cited by this paper
• Specificities and V genes encoding monoclonal autoantibodies from viable motheaten mice

  1988cited by this paper
• Peritoneal Ly‐1 B cells: Genetic control, autoantibody production, increased lambda light chain expression

  1986cited by this paper
• Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.

  1984cited by this paper
• Lyb-5- B cells of CBA/N mice can be induced to synthesize DNA by culture with insolubilized but not soluble anti-Ig.

  1983cited by this paper
• Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence

  1983cited by this paper

• The X Factor in Immunity: Sex Differences Shaped by the X Chromosome

  2026cites this paper
• B-1a Cells, but Not Marginal Zone B Cells, Are Implicated in the Accumulation of Autoreactive Plasma Cells in Lyn−/− Mice

  2024cites this paper
• Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton’s tyrosine kinase inhibitor

  2023cites this paper
• Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans

  2022cites this paper
• Emerging protein kinase inhibitors for the treatment of rheumatoid arthritis

  2021cites this paper
• Btk Supports Autoreactive B Cell Development and Protects against Apoptosis but Is Expendable for Antigen Presentation

  2021cites this paper
• Inhibition of Bruton Tyrosine Kinase Reduces Neuroimmune Cascade and Promotes Recovery after Spinal Cord Injury

  2021cites this paper
• Bruton's tyrosine kinase inhibition in the treatment of preclinical models and multiple sclerosis.

  2021cites this paper
• Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures

  2021cites this paper
• Efficacy of a Bruton's Tyrosine Kinase Inhibitor (PRN-473) in the treatment of canine pemphigus foliaceus.

  2020cites this paper
• Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models

  2019cites this paper
• The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders

  2019cites this paper
• Discovery of 4-Aminoquinoline-3-carboxamide Derivatives as Potent Reversible Bruton's Tyrosine Kinase Inhibitors for the Treatment of Rheumatoid Arthritis.

  2019cites this paper
• Structural mechanism for Bruton’s tyrosine kinase activation at the cell membrane

  2018cites this paper
• Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity

  2018influential citation
• IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate

  2018cites this paper
• Bruton’s Tyrosine Kinase, a Component of B Cell Signaling Pathways, Has Multiple Roles in the Pathogenesis of Lupus

  2018cites this paper
• Foxo3 Promotes Apoptosis of B Cell Receptor–Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing

  2018cites this paper
• METHODS OF INHIBITION OF BRUTONS TYROSINE KNASEBY SUCH COMPOUNDS

  2017cites this paper
• Reply

  2017cites this paper
• Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

  2017influential citation
• Bruton's Tyrosine Kinase Deficiency Inhibits Autoimmune Arthritis in Mice but Fails to Block Immune Complex–Mediated Inflammatory Arthritis

  2016cites this paper
• The role of Bruton’s tyrosine kinase in autoimmunity and implications for therapy

  2016cites this paper
• How will Bruton's tyrosine kinase inhibitors affect rheumatoid arthritis?

  2016cites this paper
• The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

  2016cites this paper
• Btk in the Control of Antibody Levels Genetic Interaction between Lyn, Ets1, and

  2015cites this paper
• Bruton’s tyrosine kinase in chronic inflammation: from pathophysiology to therapy

  2015cites this paper
• Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels

  2015cites this paper
• Optimal Ets1 Levels Plasma Cell Differentiation by Maintaining Inhibitory Receptor Signaling Controls A Balance between B Cell Receptor and

  2014cites this paper
• Role of the Lyn tyrosine kinase in the development of autoimmune disease

  2014cites this paper
• Bruton’s Tyrosine Kinase Promotes Persistence of Mature Anti-Insulin B Cells

  2014cites this paper
• A Balance between B Cell Receptor and Inhibitory Receptor Signaling Controls Plasma Cell Differentiation by Maintaining Optimal Ets1 Levels

  2014cites this paper
• with Lyn Deficiency Autoimmune Disease Normally Associated A Kinase-Dead Allele of Lyn Attenuates

  2013cites this paper
• IL‐21 promotes the production of anti‐DNA IgG but is dispensable for kidney damage in lyn−/− mice

  2013cites this paper
• lineages lead to poor inflammatory responses Pleiotropic consequences of Bruton's tyrosine kinase deficiency in myeloid

  2013cites this paper
• Targeting the SYK-BTK axis for the treatment of immunological and hematological disorders: recent progress and therapeutic perspectives.

  2013influential citation
• FcγRIIb and BAFF Differentially Regulate Peritoneal B1 Cell Survival

  2012cites this paper
• Modulating proximal cell signaling by targeting Btk ameliorates humoral autoimmunity and end-organ disease in murine lupus

  2012cites this paper
• Attenuation of phosphoinositide 3-kinase δ signaling restrains autoimmune disease.

  2012cites this paper
• Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK

  2010cites this paper
• Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn‐deficient mice

  2010cites this paper
• Multiple roles of Lyn kinase in myeloid cell signaling and function

  2009cites this paper
• Reduced Diabetes in btk-Deficient Nonobese Diabetic Mice and Restoration of Diabetes with Provision of an Anti-Insulin IgH Chain Transgene1

  2009cites this paper
• A Kinase-Dead Allele of Lyn Attenuates Autoimmune Disease Normally Associated with Lyn Deficiency1

  2009cites this paper
• Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.

  2008influential citation
• Btk regulates multiple stages in the development and survival of B-1 cells.

  2007cites this paper
• MyD88‐dependent autoimmune disease in Lyn‐deficient mice

  2007cites this paper
• Spontaneous class switching and B cell hyperactivity increase autoimmunity against intracellular self antigen in Lyn‐deficient mice

  2006cites this paper
• B-1 B cells: development, selection, natural autoantibody and leukemia.

  2006cites this paper
• Lyn tyrosine kinase: accentuating the positive and the negative.

  2005cites this paper
• B cell signaling and tumorigenesis.

  2005cites this paper
• Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses.

  2004cites this paper
• Role of Ets-2 in lymphocyte development, function, and survival

  2004cites this paper
• Src-family kinases in B-cell development and signaling

  2004cites this paper
• Gene expression in mononuclear cells from patients with inflammatory bowel disease.

  2004cites this paper
• Myositis and myopathies

  2003cites this paper
• Primary immune deficiency disease

  2001cites this paper
• Transgene with Provision of an Anti-insulin Igh Chain Diabetic Mice and Restoration of Diabetes -deficient Nonobese Btk Reduced Diabetes In

  year unknowncites this paper
• Peritoneal B1 Cell Survival Riib and Baff Differentially Regulate Γ Fc

  year unknowncites this paper